Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. Read our latest report on the stock here.
The quasi-privatized system called “Medicare Advantage,” otherwise known as Part C, was created in 2003 as a means of expanding the role of private sector ...
In 2016 Steve Bannon told Donald Trump that if he played his cards right, he could become “the Roosevelt of the Right.” That is, he could create a coalition of ultra-wealthy capitalists, small ...